Human Genome Epidemiology Literature Finder
Records 1 - 6 (of 6 Records) |
Query Trace: Arthritis and CYP3A4[original query] |
---|
Genetic polymorphisms in metabolic pathways of leflunomide in the treatment of rheumatoid arthritis. Clinical and experimental rheumatology 0 33 (3): 426-32. Soukup Tomas, Dosedel Martin, Nekvindova Jana, Toms Jan, Vlcek Jiri, Pavek Pe |
Relationships between concomitant biologic DMARDs and prednisolone administration and blood tacrolimus exposure or serum CYP3A4/5-related markers in rheumatoid arthritis patients. Clinical biochemistry 2019 May . Naito Takafumi, Ohshiro Junya, Sato Hikaru, Torikai Eiji, Suzuki Motohiro, Ogawa Noriyoshi, Kawakami Junic |
Physiologically based pharmacokinetic (PBPK) modeling for prediction of celecoxib pharmacokinetics according to CYP2C9 genetic polymorphism. Archives of pharmacal research 2021 Jul 44 (7): 713-724. Kim Young-Hoon, Kang Pureum, Cho Chang-Keun, Jung Eui Hyun, Park Hye-Jeong, Lee Yun Jeong, Bae Jung-Woo, Jang Choon-Gon, Lee Seok-Yo |
CYP2D6 and CYP3A4 variants influence the risk and outcome of COVID-19 infection among rheumatoid arthritis patients maintained on hydroxychloroquine. Drug metabolism and personalized therapy 2021 3 . Salem Hareedy Mohammad, Rashad Sonya Mohamed, Hetta Helal F, Hassanien Sara Mahmoud, Abdellatif Hebatallah, Hassanien Man |
Physiologically based pharmacokinetic (PBPK) modeling of meloxicam in different CYP2C9 genotypes. Archives of pharmacal research 2021 11 44 (12): 1076-1090. Cho Chang-Keun, Park Hye-Jung, Kang Pureum, Moon Sungmin, Lee Yun Jeong, Bae Jung-Woo, Jang Choon-Gon, Lee Seok-Yo |
Relationship of cytochrome P450 gene polymorphisms with blood concentrations of hydroxychloroquine and its metabolites and adverse drug reactions. BMC medical genomics 2022 02 15 (1): 23. Gao Beibei, Tan Tingfei, Cao Xi, Pan Menglu, Yang Chunlan, Wang Jianxiong, Shuai Zongwen, Xia Qu |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: